Clarinex, Desloratadine News

Oral medications for allergic rhinitis include antihistamines and decongestants.

Analyses evaluate the relationship between symptom improvement of ARIA-defined persistent allergic rhinitis and daily functioning Warsaw, Poland June 9, 2009 AERIUS significantly reduces the impact of allergy symptoms on quality of life in persistent allergic rhinitis patients with a significant disease burden, according to two post hoc analyses ...

Schering-Plough will pay $165 million to resolve a class action lawsuit alleging it failed to disclose manufacturing issues that delayed FDA approval for its allergy drug Clarinex.

Inc. today announced the settlement of all patent litigation relating to Desloratadine Tablets, 5 mg, the generic version of Schering- Plough 's Clarinex allergy medication.

Schering-Plough Corp., a major maker of prescription drugs and consumer and animal health products, reports earnings for the fourth quarter Tuesday morning.

GeoPharma Inc. said it would be able to commercially launch a generic version of the allergy drug Clarinex after settling legal action.

Jim Manzi points out that funding drug trials with public money exposes you to the inverse problems of the current system.

Dr. Reddy's Laboratories Announce Settlement of Clarinex ANDA Patent litigation With Schering Corporation and Sepracor Inc.